our products
Contact phone

Rybelsus®

Diabetes Rybelsus (Generic) Generic drugs, marketed without brand names, contain the exact same active ingredients used in their brand-name counterparts, but cost significantly less. The drugs are required to meet US Food and Drug Administration (FDA) standards for safety, purity and effectiveness.
Rybelsus

Semaglutide, which is the active ingredient in Rybelsus® tablets, is a prescription medication that lowers the amount of sugar in the blood in individuals who have type 2 diabetes. When other diabetic medications have been tried without success, your doctor may recommend Rybelsus®. This medication, together with a healthy diet and regular exercise, is the best way to control diabetes. The tablets of Rybelsus® help to reduce the amount of glucose (blood sugar) in the blood by raising the amount of insulin that is produced and reducing the amount of glucagon that is secreted. This drug may potentially cause a delay in the emptying of the stomach after a meal.

BEST DEAL!

Save 20% with

Coupon "PKVCbYFj9G"

Product Options

Qty Price Per pill Savings
30 tablet $ 269.95

Best Deal

$ 9.00
Sold out
60 tablet $ 419.95

Best Deal

$ 7.00 $ 119.95
Sold out
90 tablet $ 539.95

Best Deal

$ 6.00 $ 269.90
Sold out
Qty Price Per pill Savings
30 tablet $ 284.95

Best Deal

$ 9.50
Sold out
60 tablet $ 434.95

Best Deal

$ 7.25 $ 134.95
Sold out
90 tablet $ 562.45

Best Deal

$ 6.25 $ 292.40
Sold out
Qty Price Per pill Savings
30 tablet $ 299.95

Best Deal

$ 10.00
Sold out
60 tablet $ 449.95

Best Deal

$ 7.50 $ 149.95
Sold out
90 tablet $ 584.95

Best Deal

$ 6.50 $ 314.90
Sold out

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.

Testimonials

high quality medications

Free discreet shipping

Secure online transactions

Money-back guarantee

Fast worldwide delivery

By staying on our site you automatically agree with the storage and processing of your personal data, in accordance with our Privacy Policy.